Skip to main content
DSM
NYSE Unknown

Activist Saba Capital Launches Proxy Fight, Seeks Board Seat to Push Fund Conversion

Analysis by Arik Shkolnikov
Sentiment info
Positive
Importance info
9
Price
$6.18
Mkt Cap
$305.469M
52W Low
$5.445
52W High
$6.3
Market data snapshot near publication time

summarizeSummary

Activist investor Saba Capital Management, L.P., a 10% owner, has filed definitive additional proxy materials to solicit votes for its independent director nominee, Paul Kazarian, aiming to address persistent trading discounts and potentially convert the fund to an open-ended structure.


check_boxKey Events

  • Activist Proxy Contest Launched

    Saba Capital Management, L.P., a 10% owner, is actively soliciting votes for its independent director nominee, Paul Kazarian, to the 10-member board of BNY Mellon Strategic Municipal Bond Fund, Inc.

  • Strategic Fund Conversion Proposed

    If elected, the nominee would explore converting the closed-end fund into an open-ended fund to address persistent trading discounts and high fees, citing a similar successful reorganization by BNY Mellon in 2025.

  • Governance Concerns Highlighted

    Saba Capital criticizes the fund's classified board structure, long director tenures, lack of director stock ownership, and directors serving on numerous other BNY Mellon fund boards.

  • Shareholder Dissatisfaction Evident

    A proposal to convert the fund to an open-end structure received over 45% of votes at the 2025 annual meeting, indicating significant shareholder support for change.


auto_awesomeAnalysis

This filing signals an intensified proxy contest by Saba Capital, a prominent activist investor in closed-end funds. Saba Capital, holding a significant 10% stake, is directly challenging the current board and management of BNY Mellon Strategic Municipal Bond Fund, Inc. by nominating its own director. The core of their argument revolves around the fund's persistent trading discount to NAV, perceived poor governance (classified board, long tenures, lack of director stock ownership), and high fees. The proposed solution, if their nominee is elected, is to explore converting the closed-end fund into an open-ended fund, a move that has historical precedent within BNY Mellon and could potentially eliminate the discount and reduce fees for shareholders. The fact that a similar proposal nearly passed in 2025 underscores existing shareholder dissatisfaction. Investors should closely monitor the outcome of this proxy vote as it could lead to significant structural changes and value realization for shareholders.

At the time of this filing, DSM was trading at $6.18 on NYSE in the Unknown sector, with a market capitalization of approximately $305.5M. The 52-week trading range was $5.45 to $6.30. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed DSM - Latest Insights

DSM
May 07, 2026, 10:00 AM EDT
Filing Type: DFAN14A
Importance Score:
9
DSM
May 06, 2026, 3:42 PM EDT
Filing Type: DEFA14A
Importance Score:
7
DSM
Apr 29, 2026, 3:45 PM EDT
Filing Type: DEFC14A
Importance Score:
8
DSM
Apr 16, 2026, 1:20 PM EDT
Filing Type: PREC14A
Importance Score:
8
DSM
Apr 14, 2026, 6:04 PM EDT
Filing Type: PREC14A
Importance Score:
8